GRIFFIN ASSET MANAGEMENT, INC.

Position in SANA — Sana Biotechnology, Inc.

CIK 883803 New York, NY

Position in SANA

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$51,023

+$8,918 QoQ

Shares Held

14,620

0.0% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#143

of 211 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GRIFFIN ASSET MANAGEMENT, INC. holds $6,668,181 across 5 Biotechnology names. SANA ranks #5 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,142	$3,050,915
2	SMMT	Summit Therapeutics Inc.	193,582	$2,820,489
3	ABSI	Absci Corp	56,760	$657,848
4	BMEA	Biomea Fusion, Inc.	59,800	$87,906
5	SANA	Sana Biotechnology, Inc. This page	14,620	$51,023

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$51,023	14,620	0.0%	Shares	Sole	2026-07-23
2026-03-31	$42,105	14,620	+25.8%	Shares	Sole	2026-04-30
2025-12-31	$47,293	11,620	0.0%	Shares	Sole	2026-02-06
2025-09-30	$41,251	11,620	—	Shares	Sole	2025-10-16
No filing history on record for this holder in this stock.